Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 309

Similar articles for PubMed (Select 14597358)

1.

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists.

Rodrigues G, D'Souza D, Crook J, Malone S, Sathya J, Morton G.

Radiother Oncol. 2003 Oct;69(1):63-72.

PMID:
14597358
2.

Current opinion on adjuvant and salvage treatment after radical prostatectomy.

Morris SL, Parker C, Huddart R, Horwich A, Dearnaley D.

Clin Oncol (R Coll Radiol). 2004 Jun;16(4):277-82.

PMID:
15214652
3.

Changing management of localized prostate cancer: a comparison survey of Ontario radiation oncologists.

Martin J, Rodrigues G, Malone S, Morton G, Campbell H, Crook J.

Can J Urol. 2006 Apr;13 Suppl 2:26-33.

PMID:
16672125
4.

Initiation of salvage therapy for prostate cancer.

Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW.

Prostate Cancer Prostatic Dis. 2002;5(2):136-43.

5.
6.

Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.

Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finkelstein J, Andersson L, Connolly R.

Radiother Oncol. 2000 Sep;56(3):305-14.

PMID:
10974379
7.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
8.

Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK.

Lee LW, Clarke NW, Ramani VA, Cowan RA, Wylie JP, Logue JP.

Prostate Cancer Prostatic Dis. 2005;8(3):229-34.

PMID:
15999120
9.

High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful?

Cellini N, Pompei L, Fortuna G, Ammaturo MV, De Paula U, Luzi S, Mattiucci GC, Morganti AG, Digesù C, Rosetto ME, Palloni T, Petrongari MG, Gentile P, Deodato F, Valentini V.

Tumori. 2004 Mar-Apr;90(2):201-7.

PMID:
15237583
11.

Neoadjuvant hormonal therapy in the management of prostate cancer: a surgical and radiation therapy review.

Soderdahl DW, Wettlaufer JN, Corn B, Gomella LG.

Tech Urol. 1996 Winter;2(4):194-206. Review.

PMID:
9085540
12.

Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.

Showalter TN, Ohri N, Teti KG, Foley KA, Keith SW, Trabulsi EJ, Lallas CD, Dicker AP, Hoffman-Censits J, Pizzi LT, Gomella LG.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e233-8. doi: 10.1016/j.ijrobp.2011.04.003. Epub 2011 May 24.

13.

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.

McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ Jr.

Urology. 2002 Oct;60(4):628-33.

PMID:
12385923
14.

Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.

Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, Breau RH.

PLoS One. 2013 Nov 4;8(11):e79773. doi: 10.1371/journal.pone.0079773. eCollection 2013.

15.

Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.

Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL.

Urology. 2013 Oct;82(4):807-12. doi: 10.1016/j.urology.2013.04.060. Epub 2013 Aug 1.

PMID:
23910088
16.

What to do for prostate cancer patients with a rising PSA?--A survey of Australian practice.

Duchesne GM, Millar JL, Moraga V, Rosenthal M, Royce P, Snow R.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):986-91.

PMID:
12605977
17.

Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000.

Chong CC, Austen L, Kneebone A, Lalak A, Jalaludin B.

BJU Int. 2006 May;97(5):975-80. Epub 2006 Mar 17.

PMID:
16542341
18.

The management of high risk prostate cancer.

Akduman B, Crawford ED.

J Urol. 2003 Jun;169(6):1993-8. Review.

PMID:
12771704
19.

Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.

Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):993-1002.

PMID:
15752878
20.

Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy.

Samper PM, López Carrizosa MC, Pérez Casas A, Vallejo C, Rubio Rodríguez MC, Pérez Vara C, Melchor Iñiguez M.

Clin Transl Oncol. 2006 Aug;8(8):599-605.

PMID:
16952849
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk